Venture Life Group (LON:VLG) Sets New 52-Week High – Still a Buy?

Venture Life Group plc (LON:VLG)’s stock price reached a new 52-week high during mid-day trading on Monday . The company traded as high as GBX 67 and last traded at GBX 66.71, with a volume of 130481 shares trading hands. The stock had previously closed at GBX 65.50.

Venture Life Group Trading Up 1.8%

The firm has a market capitalization of £85.12 million, a PE ratio of -87.78, a P/E/G ratio of 5.67 and a beta of 0.30. The company has a quick ratio of 1.48, a current ratio of 2.22 and a debt-to-equity ratio of 28.45. The business’s fifty day moving average price is GBX 60.18 and its 200 day moving average price is GBX 58.22.

Venture Life Group Company Profile

Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the global self-care market.

With operations in the UK, The Netherlands and Italy, the Group’s product portfolio includes some key products such as the UltraDEX and Dentyl oral care product ranges, food supplements for maintaining brain function, medical devices for women’s intimate healthcare, fungal infections and proctology, and dermo-cosmetics for addressing the signs of ageing.

The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies and grocery multiples.